Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo

Biomaterials

Volumn 32, Issue 2, 2011, Pages 495-502

  Xie, Hui ^a   Zhu, Yanhong ^a   Jiang, Weili ^a   Zhou, Qing ^a   Yang, Hai ^a   Gu, Ning ^b   Zhang, Yu ^b   Xu, Huibi ^a   Xu, Haibo ^a   Yang, Xiangliang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Contrast agent; Glioma; Lactoferrin; Magnetic resonance imaging; Superparamagnetic iron oxide

Indexed keywords

BRAIN TISSUE; BRAIN TUMORS; CONTRAST AGENT; ENHANCED T; GLIOMA; HIGH LEVEL EXPRESSION; HYDRODYNAMIC DIAMETER; IN-VIVO; LACTOFERRIN; MR IMAGES; MRI CONTRAST AGENTS; RAT MODEL; RELAXIVITY; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLES; SUPERPARAMAGNETIC IRON OXIDES; SURGICAL OPERATION; WESTERN BLOTS;

HISTOLOGY; IRON OXIDES; NANOPARTICLES; RADIOLOGY; RESONANCE; SATURATION MAGNETIZATION; SUPERPARAMAGNETISM; SURGERY; TUMORS;

MAGNETIC RESONANCE IMAGING;

LACTOFERRIN; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; BRAIN TUMOR; CANCER DIAGNOSIS; CONJUGATION; CONTROLLED STUDY; GLIOMA; HUMAN; HUMAN CELL; HYDRODYNAMICS; IN VITRO STUDY; IN VIVO STUDY; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CONTRAST MEDIA; FERROSOFERRIC OXIDE; GLIOMA; HUMANS; LACTOFERRIN; MAGNETIC RESONANCE IMAGING; NANOPARTICLES; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

RATTUS;

EID: 78449246337     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.09.024     Document Type: Article

References (30)

1. Koo Y.-E.L., Reddy G.R., Bhojani M., Schneider R., Philbert M.A., Rehemtulla A., et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev 2006, 58:1556-1577.
2. Claes A., Idema A.J., Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol 2007, 114:443-458.
3. Rees J. Advances in magnetic resonance imaging of brain tumors. Curr Opin Neurol 2003, 16:643-650.
4. Cao Y., Sundgren P.C., Tsien C.I., Chenevert T.T., Junck L.J. Physiologic and metabolic magnetic resonance imaging in gliomas. J Clin Oncol 2006, 24:1228-1235.
5. Crich S.G., Cabella C., Barge A., Belfiore S., Ghirelli C., Lattuada L., et al. In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes. J Med Chem 2006, 49:4926-4936.
6. Pan D., Caruthers S.D., Hu G., Senpan A., Scott M.J., Gaffney P.J., et al. Ligand-directed nanobialys as theranostic agent for drug delivery and manganese-based magnetic resonance imaging of vascular targets. J Am Chem Soc 2008, 130:9186-9187.
7. Varallyay P., Nesbit G., Muldoon L.L., Nixon R.R., Delashaw J., Cohen J.I., et al. Comparison of two superparamagnetic viral-sized iron oxide particles ferumoxides and ferumoxtran-10 with a gadolinium chelate in imaging intracranial tumors. Am J Neuroradiol 2002, 23:510-519.
8. Zhou B., Shan H., Li D., Jiang Z.B., Qian J.S., Zhu K.S., et al. MR tracking of magnetically labeled mesenchymal stem cells in rats with liver fibrosis. Magn Reson Imaging 2010, 28:394-399.
9. Reddy G.R., Bhojani M.S., McConville P., Moody J., Moffat B.A., Hall D.E., et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res 2006, 12:6677-6686.
10. Veiseh O., Sun C., Gunn J., Kohler N., Gabikian P., Lee D., et al. Optical and MRI multifunctional nanoprobe for targeting gliomas. Nano Lett 2005, 5:1003-1008.
11. Kircher M.F., Mahmood U., King R.S., Weissleder R., Josephson L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 2003, 63:8122-8125.
12. Jeffrey P.D., Bewley M.C., MacGillivray R.T. Ligand-induced conformational change in transferrins: crystal structure of the open form of the N-terminal half-molecule of human transferring. Biochemistry 1998, 37:13978-13986.
13. Recht L., Torres C.O., Smith T.W., Raso V., Griffin T.W. Transferrin receptor in normal and neoplastic brain tissue: implications for brain-tumor immunotherapy. J Neurosurg 1990, 72:941-945.
14. Pardridge W.M., Eisenberg J., Yang J. Human blood-brain barrier transferrin receptor. Metabolism 1987, 36:892-895.
15. Huang R.Q., Ke W., Liu Y., Jiang C., Pei Y.Y. The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain. Biomaterials 2008, 29:238-246.
16. Strickland D.K., Gonias S.L., Argraves W.S. Diverse roles for the LDL receptor family. Trends Endocrinol Metab 2002, 13:66-74.
17. Demeule M., Currie J.-C., Bertrand Y., Che C., Nguyen T., Regina A., et al. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem 2008, 106:1534-1544.
18. Zhang S., Bian Z.P., Gu C.R., Zhang Y., He S.Y., Gu N., et al. Preparation of anti-human cardiac tropon in I immunomagnetic nanoparticles and biological activity assays. Colloid Surf B 2007, 55:143-148.
19. Grey A., Banovic T., Zhu Q., Watson M., Callon K., Palmano K., et al. Low-density lipoprotein receptor-related protein 1 is a mitogenic receptor for lactoferrin in osteoblastic cells. Mol Endocrinol 2004, 18:2268-2278.
20. Lillis A.P., Vanduyn L.B., Murphy-Ullrich J.E., Strickland D.K. LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev 2008, 88:887-918.
21. Fleige G., Nolte C., Synowitz M., Seeberger F., Kettenmann H., Zimmer C. Magnetic labeling of activated microglia in experimental gliomas. Neoplasia 2001, 3:489-499.
22. Corot C., Robert P., Idée J.M., Port M. Recent advances in iron oxide nanocrystal technology for medical imaging. Adv Drug Deliv Rev 2006, 58:1471-1504.
23. Li W., Szoka F.C. Lipid-based nanoparticles for nucleic acid delivery. Pharm Res 2007, 24:438-449.
24. Vorbrodt A.W., Dobrogowska D.H., Tarnawski M., Lossinsky A.S. A quantitative immunocytochemical study of the osmotic opening of the blood-brain barrier to endogenous albumin. J Neurocytol 1994, 23:792-800.
25. Leslie M.L., Michael A.P., Robert A.K., Simon R.-G., Russell S.J., Edward A.N. A physiological barrier distal to the anatomic blood- brain barrier in a model of transvascular delivery. Am J Neuroradiol 1999, 20:217-222.
26. Fillebeen C., Descamps L., Dehouck M.P. Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier. J Biol Chem 1999, 274:7011-7017.
27. Giese A., Bjerkvig R., Berens M.E., Westphal M.J. Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 2003, 21:1624-1636.
28. Sun C., Veiseh O., Gunn J., Fang C., Hansen S., Lee D., et al. In vivo MRI detection of gliomas by chlorotoxin-conjugated superparamagnetic nanoprobes. Small 2008, 4:372-379.
29. Faucheux B.A., Nillesse N., Damier P., Spik G., Mouatt-Prigent A., Pierce A. Expression of lactoferrin receptors is increased in the mesencephalon of patients with parkinson disease. Proc Natl Acad Sci U S A 1995, 92:9603-9607.
30. Kawamata T., Tooyama I., Yamada T., Walker D.G., McGeer P.L. Lactotransferrin immunocytochemistry in Alzheimer and normal human brain. Am J Pathol 1993, 142:1574-1585.